Martin Bonamino | Head of Cell and Gene Therapy Program
National Cancer Institute of Brazil

I received my PhD in biological chemistry from the Federal university of Rio de Janeiro in 2004. I lead the Program for Cell and Gene Therapy at the Brazilian National Cancer institute in Rio de Janeiro. We were the pioneer group in Brazil in CAR-T cell development and have contributed to the field by developing protocols for cost-effective generation of such cell products. From 2015 I also joined the Fundação Oswaldo Cruz, the largest health institution in Brazil, where I co-coordinate the recently established institutional program for cancer research. In addition to contributing to the cancer, tumor immunology, synthetic biology and gene therapy fields, I had the opportunity to contribute to the establishment of the regulatory framework for cell and gene therapies in Brazil as a member of the advisory committee of ANVISA, the Brazilian regulatory agency.